会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • 랄록시펜의 신규한 제조 방법
    • 新的合成方法
    • KR100803746B1
    • 2008-02-15
    • KR1020060127513
    • 2006-12-14
    • 하나제약 주식회사
    • 장사정이재목강성구
    • C07D409/12
    • A method for preparing raloxifene is provided to be able to shorten the reaction time, simplify the post-process, and be very simple for isolating and purifying with generating almost no side products, thereby being adequate for industrial preparation of the raloxifene and obtaining the raloxifene with high purity and high yield. A method for preparing raloxifene comprises the steps of: (a) acylating 6-methoxy-2-(4-methoxyphenyl)benzo[b]thiophene represented by the formula(2) and 4-fluorobenzoic acid chloride represented by the formula(3) under a Lewis acid catalyst such as FeCl3 to prepare 6-methoxy-2-(4-methoxyphenyl)-3-(4-fluorobenzoyl)benzo[b]thiophene represented by the formula(4); (b) reacting the compound of the formula(4) with 2-hydroxyethylpiperidine represented by the formula(5) in the presence of a base to prepare 6-methoxy-2-(4-methoxyphenyl)-3-[4-(2-piperidinoethoxy_benzoyl]benzo[b]thiophene hydrochloride represented by the formula(6); and (c) de-protecting the compound of the formula(6) using pyridium hydrochloride to prepare 6-hydroxy-2-(4-hydroxyphenyl)-3-[4-2-piperidinoethoxy)benzoyl]benzo[b]thiophene hydrochloride represented by the formula(1). Further, the 0.1-0.5 equivalent of FeCl3 is used based on the 6-methoxy-2-(4-methoxyphenyl)-3-(4-fluorobenzoyl)benzo[b]thiophene in the acylating step.
    • 提供制备雷洛昔芬的方法能够缩短反应时间,简化后期处理,并且分离和纯化非常简单,几乎不产生副产物,从而足以工业制备雷洛昔芬并获得雷洛昔芬 纯度高,产量高。 制备雷洛昔芬的方法包括以下步骤:(a)酰化由式(2)表示的6-甲氧基-2-(4-甲氧基苯基)苯并[b]噻吩和由式(3)表示的4-氟苯甲酰氯, 在路易斯酸催化剂如FeCl 3之下,制备由式(4)表示的6-甲氧基-2-(4-甲氧基苯基)-3-(4-氟苯甲酰基)苯并[b]噻吩; (b)使式(4)的化合物与式(5)所示的2-羟乙基哌啶在碱的存在下反应,得到6-甲氧基-2-(4-甲氧基苯基)-3- [4-(2 (6)表示的苯并[b]噻吩盐酸盐;和(c)使用盐酸吡啶鎓脱保护式(6)的化合物,以制备6-羟基-2-(4-羟基苯基)-3 - 由式(1)表示的[4-2-哌啶子基乙氧基)苯甲酰基]苯并[b]噻吩盐酸盐。 此外,在酰化步骤中,基于6-甲氧基-2-(4-甲氧基苯基)-3-(4-氟苯甲酰基)苯并[b]噻吩,使用0.1-0.5当量的FeCl 3。
    • 5. 发明授权
    • 1,2,3,9-테트라하이드로-9-메틸-3-[(2-메틸-1H-이미다졸-1-일)메틸]-4H-카바졸-4-온의 제조방법
    • 1,2,3,9-테트라하이드로-9-메틸-3 - [(2-메틸1H이미다졸-1-일)메틸] -4H-카바졸-4-온의제조방1,2,3
    • KR100393744B1
    • 2003-08-02
    • KR1020000072731
    • 2000-12-02
    • 하나제약 주식회사
    • 장사정서경재김치현
    • C07D403/06
    • PURPOSE: Provided a method for preparing 1,2,3,9-tetrahydro-9-methyl-3- ((2-methyl-1h-imidazol-1-yl)methyl)-4h-carbazol-4-one represented by the formula(1), which does not involves separation and purification processes of intermediates, thus economically manufacture the compound of the formula(1) by one-pot reaction. CONSTITUTION: 1,2,3,9-tetrahydro-9-methyl-3- ((2-methyl-1h-imidazol-1-yl)methyl)-4h-carbazol-4-one represented by the formula(1) is manufactured by reacting 4H-carbazol-4-one of the formula(2) and amine compound of the formula(3) with catalyst to synthesize enamine intermediate; continuously reacting the enamine intermediate with dihalogenated methane and 2-methylimidazole; and hydrolyzing the resultant compound to obtain a compound of the formula(1).
    • 目的:提供一种制备1,2,3,4-四氢-9-甲基-3 - ((2-甲基-1H-咪唑-1-基)甲基)-4H-咔唑-4-酮的方法 式(1)不涉及中间体的分离和纯化过程,因此经济地通过一锅反应制备式(1)的化合物。 构成:由式(1)表示的1,2,3,9-四氢-9-甲基-3 - ((2-甲基-1H-咪唑-1-基)甲基)-4H-咔唑-4-酮为 通过使式(2)的4H-咔唑-4-酮和式(3)的胺化合物与催化剂反应以合成烯胺中间体而制备; 使烯胺中间体与二卤代甲烷和2-甲基咪唑连续反应; 并水解得到的化合物,得到式(1)的化合物。
    • 8. 发明授权
    • 수지재 앰플의 제조장치
    • 塑料安瓿制造装置
    • KR101109621B1
    • 2012-02-06
    • KR1020100007978
    • 2010-01-28
    • 화인에프.에이 주식회사하나제약 주식회사
    • 박종현
    • A61J1/00A61J1/06
    • 본 발명은 챔버(10) 내에서 컨베이어(12)로 이송하며 수지재 앰플(A)을 제조하는 장치에 있어서: 상기 챔버(10) 내부로 다수의 앰플(A)을 투입하여 컨베이어(12) 상에 도립 상태로 안착하는 로딩부(20); 상기 앰플(A)을 도립 상태로 지지하며 하측의 입구를 절단하는 절단부(30); 상기 앰플(A)을 도립 상태로 지지하며 입구의 이물질을 제거하는 파티클제거부(40); 상기 앰플(A)을 정립 상태로 지지하며 약액을 주입하는 충진부(50); 상기 앰플(A)을 정립 상태로 지지하며 절단된 입구를 열융착으로 밀봉하는 밀봉부(60); 및 상기 완성된 앰플(A)을 챔버(10)의 외부로 배출하는 언로딩부(70);를 포함하여 이루어지는 것을 특징으로 한다.
      이에 따라, 연속적인 투입과 배출을 기반으로 하는 양산 시스템에서 파티클이 혼입되지 않아 품질 저하를 방지하고 양호한 생산성을 유지할 수 있는 효과가 있다.
    • 9. 发明公开
    • 모사프리드 제조용 중간체의 제조방법
    • 用于MOSAPRIDE的中间件的新型合成方法
    • KR1020090100759A
    • 2009-09-24
    • KR1020080026156
    • 2008-03-21
    • 하나제약 주식회사
    • 공준수문창상이재목장사정
    • C07D295/033
    • PURPOSE: A method for manufacturing an intermediate for producing a mosapride is provided to ensure stability of reaction and environmental harmlessness. CONSTITUTION: A method for manufacturing an intermediate of the chemical formula II for producing mosapride comprises a step of cyclizing a compound of the chemical formula V under the presence of triphenylphospin (PPh3) or n-tributylphospin (n-Bu3P) and dialkyl azodicarboxylate of the chemical formula XII to produce a compound of the chemical formula VI; a step of reacting the compound of the chemical formula VI with a compound of the chemical formula VII to produce a compound of the chemical formula VIII; and a step of reacting the compound of the chemical formula VIII with methyl amine.
    • 目的:提供一种制备用于制备莫沙必利的中间体的方法,以确保反应的稳定性和环境无害性。 构成:制备用于制备莫沙必利的化学式II的中间体的方法包括在三苯基膦(PPh 3)或正三丁基磷(n-Bu 3 P)和偶氮二羧酸二烷基酯存在下使化学式V的化合物环化的步骤 化学式XII以产生化学式VI的化合物; 使化学式VI的化合物与化学式VII的化合物反应以制备化学式VIII的化合物的步骤; 和使化学式VIII的化合物与甲胺反应的步骤。
    • 10. 发明授权
    • 1-메틸인다졸-3-카르복실산의 제조방법
    • 1-메틸인다졸-3-카르복실산의제조방법
    • KR100424341B1
    • 2004-03-24
    • KR1020010065332
    • 2001-10-23
    • 하나제약 주식회사
    • 서경재김치현장사정
    • C07D231/56
    • PURPOSE: A process for preparing 1-methylindazol-3-carboxylic acid is provided, thereby the 1-methylindazol-3-carboxylic acid can be simply prepared without producing isomers. CONSTITUTION: The process for preparing 1-methylindazol-3-carboxylic acid of formula(1) comprises the steps of: oxidation of halophenyl acetate of formula(2) to prepare a pyruvate compound of formula(3); condensation of the pyruvate compound of formula(3) with methylhydrazine to prepare a hydrazone compound of formula(4); cyclization of the hydrazone compound of formula(4) under the acidic condition to prepare 1-methylindazol-3-carboxylic acid ester of formula(5); and hydrolysis of the compound of formula(5), wherein R is C1-6 alkyl, C3-7 cycloalkyl, phenyl or phenyl-C1-3 alkyl; and X is halogen atom.
    • 目的:提供一种制备1-甲基吲唑-3-羧酸的方法,由此可以简单制备1-甲基吲唑-3-羧酸而不产生异构体。 构成:制备式(1)的1-甲基吲唑-3-甲酸的方法包括以下步骤:氧化式(2)的卤代苯基乙酸酯以制备式(3)的丙酮酸化合物; 式(3)的丙酮酸化合物与甲基肼缩合制备式(4)的腙化合物; 在酸性条件下环化式(4)的腙化合物以制备式(5)的1-甲基吲唑-3-羧酸酯; 和式(5)化合物的水解,其中R为C 1-6烷基,C 3-7环烷基,苯基或苯基-C 1-3烷基; 并且X是卤素原子。